Latest stories on BLRX
BioLineRx Ltd. (BLRX) Q1 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
BioLineRx Shares Advance After First Patient Enrolled in GLIX1 Cancer Study (BLRX)
Yahoo Top61 · neutralearnings
BioLineRx GAAP EPS of $0.00 beats by $1.04, revenue of $0.48M beats by $0.14M
Seeking Alpha68 · bullishearnings
BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update
PR Newswire61 · neutralearnings
BioLineRx and Hemispherian Showcase New GLIX1 Data Ahead of ASCO 2026 as First-in-Human GBM Trial Enrolls
TipRanks58 · neutralproduct/pr
BioLineRx and Hemispherian AS Highlight New Data on GLIX1 at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
PR Newswire58 · neutralproduct/pr
BioLineRx to Report First Quarter 2026 Results on May 27, 2026
PR Newswire50 · neutralearnings
BioLineRx and Hemispherian Report Strong Preclinical GLIX1 Data in Temozolomide-Resistant Glioblastoma
TipRanks67 · bullishproduct/pr